Mayor Crombie was joined by Minister of Finance Bill Morneau; Navdeep Bains, Minister of Innovation, Science and Economic Development; Members of Parliament Peter Fonseca (Mississauga East-Cooksville); Gagan Sikand (Mississauga-Streetsville); Sven Spengemann (Mississauga-Lakeshore); and Member of Provincial Parliament Bob Delaney (Mississauga-Streetsville), for a tour of Therapure Biopharma, a global biomanufacturing company in Mississauga. THE CANADIAN PRESS IMAGES/J.P. Moczulski.
For Immediate Release
May 9th, 2016
Mayor Crombie Highlights Thriving Life Science Sector to Finance and Innovation Ministers
Mississauga – Our City is home to Canada’s second largest life sciences cluster in Canada, Mayor Bonnie Crombie said last week during a tour of Therapure Biopharma, a global biomanufacturing company in Mississauga.
Mayor Crombie was joined by Minister of Finance Bill Morneau; Navdeep Bains, Minister of Innovation, Science and Economic Development; Members of Parliament Peter Fonseca (Mississauga East-Cooksville); Gagan Sikand (Mississauga-Streetsville); Sven Spengemann (Mississauga-Lakeshore); and Member of Provincial Parliament Bob Delaney (Mississauga-Streetsville).
Last Friday Minister Morneau marked his first official visit to Mississauga City Hall. Minister Morneau, joined by Minister Bains, discussed with Mayor Crombie a number of Council-approved priorities, including the competitiveness of Mississauga’s local economy.
“Our Pill Hill community is a thriving hub of global life science businesses,” Mayor Crombie said. “We are currently home to more than 380 life science companies that employ more than 25,000 people.”
During the day of visit, Nick Green, President and CEO of Therapure Biopharma Inc., said “We were delighted to host the delegation today, who recognized us as one of the country’s most successful growth companies in the innovation and manufacture of biologics. It was a great opportunity to demonstrate how the contribution under the Advanced Manufacturing Fund (AMF) is being used to develop our PlasmaCap™ technology and scale-up to clinical manufacture of plasma proteins.”
Mayor Crombie said Mississauga’s life sciences talent base has grown 25% in the past 10 years, adding that, “the Wynne government recently announced it will invest up to $4.22 million in Baylis Medical Company to support a research and development expansion project at the company’s Mississauga manufacturing plant that will increase exports, create 84 new jobs and retain 194 positions.
Mayor Crombie highlighted Mississauga’s highly educated workforce as one of the many reasons why the City has a strong and growing life science sector. “Mississauga is home to the University of Toronto Mississauga (UTM) Academy of Medicine. UTM also offers a Masters of Biotechnology – one of the few programs of its kind in Canada.”
Mayor Crombie recently led an Investment Mission to Japan, which included meetings in Osaka – Japan’s global life sciences hub.
Mayor Crombie added “In June, I will join the team of professionals from the City of Mississauga’s Economic Development Office (EDO) for the 2016 BIO International Convention. More than 15,000 delegates are expected to attend the life-sciences conference, the largest in the world.
“We will meet and network with industry experts, investors, stakeholders and partners, with the goal to strengthen relationships and leverage Mississauga and Ontario’s competitive advantage in the life sciences sector.”
“We will share Mississauga and Canada’s success story as a leading place for businesses to invest, expand service offerings and remain ahead of the competition,” Mayor Crombie concluded.
-30-